Baxalta

GAMMAGARD LIQUID

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Baxalta

Gammagard Liquid HCPCS:

J1569

HCPCS Code Descriptor:

Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

Category:

J Code

Gammagard Liquid NDCs:

00944-2700-03, 00944-2700-04, 00944-2700-02, 00944-2700-07, 00944-2700-06, 00944-2700-05

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Gammagard Liquid CPT Codes:

Potential CPT administration codes for Gammagard Liquid can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gammagard Liquid:

GAMMAGARD LIQUID is an Immunoglobulin drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J1569 is aligned to the drug GAMMAGARD LIQUID.

ACCESS PRICING AND MORE BY REGISTERING

J1569 Added Date:

January 1, 2008

J1569 Effective Date:

January 1, 2013

J1569 Termination Date:

HCPCS Active

Gammagard Liquid billing and coding information can be found through Baxalta at the link below:
Gammagard Liquid patient assistance information can be found through Takeda Patient Support at the URL: https://www.gammagard.com/primary-immunodeficiency/copay-support
GAMMAGARD LIQUID prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for GAMMAGARD LIQUID. Please check back in a few weeks.